SAN DIEGO, CA, Sept. 04, 2026 (GLOBE NEWSWIRE) -- After building its initial patient base through online GLP-1 care under the OnlineSemaglutide.org brand, telehealth provider Raeliva is entering its next chapter with an expanded focus on virtual wellness care. While weight management remains part of the platform, the company is broadening its focus to include additional wellness categories, including longevity, hormone health, hair health, and other areas of care subject to individual clinical eligibility.
The expanded model builds on the patient experience and telehealth foundation established through OnlineSemaglutide.org. Raeliva said it has supported more than 1,000 patients and is now developing its platform around access to licensed medical providers, patient education, and eligible treatment options fulfilled through U.S.-licensed compounding pharmacies.
The company said the next phase of its platform will move beyond a narrow focus on GLP-1 treatments to encompass a wider range of wellness categories, including weight management, longevity, hormones, and other areas of patient care. Raeliva’s stated goal is to develop an online clinic that patients can continue to use as their healthcare priorities evolve.
Raeliva has supported more than 1,000 patients and is now establishing its brand around a broader approach to virtual wellness care. The company’s model combines access to licensed medical providers with eligible treatment options fulfilled through U.S. licensed compounding pharmacies.
“Raeliva is being built as more than a peptide supplier,” the company's Tyler Cooper said. “The focus is on creating an online wellness clinic where patients can access medical guidance, education, and treatment options through an ongoing healthcare relationship.”
Weight management remains an important part of the platform, with semaglutide and tirzepatide available when clinically appropriate. The company is also expanding its focus on peptide and longevity medicine, including treatment options such as NAD+ and Sermorelin. Additional wellness categories, including hormone and hair health, are planned for future expansion.
The company said its approach is intended to place patient communication and education alongside treatment access. Rather than centering its platform on a single medication category, Raeliva is developing a broader care model that can accommodate changing patient interests and healthcare needs.
For example, an individual may initially seek virtual care related to weight management and later explore other areas of wellness, such as energy, recovery, hormone health, or hair health. Raeliva said its broader platform is designed to provide a consistent point of access as those priorities change.
The company also emphasized a distinction between medically supervised treatment and products marketed as research-grade peptides that are not intended for human use. Raeliva’s model is based on licensed-provider review and pharmacy fulfillment rather than the sale of research-use peptide products.
Each patient begins with an online intake that is reviewed by a licensed medical provider. Prescriptions are issued only when clinically appropriate. Where compounded medications are eligible for use, fulfillment is handled through U.S. licensed compounding pharmacies.
Raeliva said transparency is another component of its expanded model. Patients are provided with information regarding treatment options, pricing, and what to expect before proceeding with care. The company describes this as part of its effort to establish a more direct relationship with patients throughout their healthcare journey.
The rebrand comes as Raeliva develops its position in online wellness and peptide-focused telehealth. Its platform includes areas associated with GLP-1 medications, semaglutide, tirzepatide, NAD+, Sermorelin, and other peptide-related wellness offerings, subject to individual clinical eligibility.
Raeliva provides telehealth access to licensed medical providers and treatment options based on individual clinical eligibility. Compounded medications are not FDA-approved and are not the same as brand-name products. Results may vary. Prescriptions require an online consultation with a licensed provider.
The company’s expanded online wellness clinic is available through Raeliva.com.
About Raeliva
Raeliva is a San Diego, California-based telehealth company developing an online wellness clinic focused on peptides, education, medical oversight, and patient support. The company provides access to licensed medical providers and treatment options based on individual clinical eligibility, with eligible compounded medications fulfilled through U.S. licensed compounding pharmacies.
Media Contact Company Name: Raeliva Contact Person: Tyler Cooper Email: hello@raeliva.com Country: United States Website: Raeliva
